SUPERNUS PHARMACEUTICALS, INC. (SUPN)
About SUPERNUS PHARMACEUTICALS, INC.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $719.0M
- Net income
- -$38.5M
- Total assets
- $1.5B
- Market cap
- $2.7B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.7B
- Shares outstanding
- 65.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 1, 2012
Supernus Pharmaceuticals, Inc. (SUPN) Stock Price
- Reported a net loss of $38.5M in FY2025.
- Trading 29% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SUPERNUS PHARMACEUTICALS, INC..
Write a review
News about SUPERNUS PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Supernus Pharmaceuticals, Inc.: frequently asked questions
Is Supernus Pharmaceuticals, Inc. an American company?
Supernus Pharmaceuticals, Inc. is a US-based company headquartered in Rockville, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Supernus Pharmaceuticals, Inc. headquartered?
Supernus Pharmaceuticals, Inc. is headquartered in Rockville, Maryland, United States.
Is Supernus Pharmaceuticals, Inc. publicly traded?
Yes — Supernus Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol SUPN on the NASDAQ.
What does Supernus Pharmaceuticals, Inc. do?
Supernus Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
